main content start
¿Le gustó este contenido?
Content
Myelodysplastic Syndromes 2m 25s

Factors that influence treatment adherence and outcomes in MDS

Downloadable slides curated by experts

Please watch the video to access Medslides

Publicado11 Jul 2022
Anticipate & manage adverse events to optimize treatment outcomes: Patients treated with hypomethylating agents are at increased risk of cytopenias & might need support with transfusions.
adverse events hypomethylating agents mds treatment compliance

Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.

Ventajas de registrarse en MedEnrich
Contenido en línea en varios formatos
Contenido personalizado
Acceso ilimitado a todas las funciones
Hi, can I help?
Chat de ayudaX
Equipo de soporte
¡Hola! ¿Cómo puedo ayudarlo/a hoy?
Por favor seleccione alguna de las siguientes opciones.

Buscar información

Problemas con el inicio de sesión o registro

Compartir un comentario